New Zealand's largest private health insurer is reassuring members will get access to the latest breast cancer screening technology at no extra cost, after a report by the Herald on Sunday.
In September, Southern Cross came under fire for not approving tomosynthesis - new digital scanning which researchers say can help detect cancer 40 per cent earlier than a conventional mammogram.
Many private health insurers in New Zealand have already recognised the evidence behind tomosynthesis and include it in policies, including Accuro, Sovereign and nib. But Southern Cross had not approved it, despite private Kiwi clinics lobbying them for months.
Labour Party deputy leader Annette King followed up on the report by writing to Southern Cross, requesting the insurer explain its position.
And in a response to the Opposition health spokeswoman last month, the company revealed patients who are being told they need access to tomosynthesis are being granted it, without any top-up fees or further assessments.
